Literature DB >> 22039304

c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus.

Teruhiko Kozuka1, Mayumi Sugita, Susan Shetzline, Alan M Gewirtz, Yuji Nakata.   

Abstract

The c-Myb and GATA-3 transcription factors play important roles in T cell development. We recently reported that c-Myb, GATA-3, and Menin form a core transcription complex that regulates GATA-3 expression and ultimately Th2 cell development in human peripheral blood T cells. However, c-Myb roles for Th2 cytokine expression were not demonstrated. In this article, we report that c-Myb and GATA-3 cooperatively play an essential role in IL-13 expression though direct binding to a conserved GATA-3 response element (CGRE), an enhancer for IL-13 expression. c-Myb and GATA-3 were shown to activate the CGRE-IL-13 promoter by ∼160-fold, and mutation of the canonical Myb binding site completely abrogated CGRE enhancer activity. In contrast, mutation of the GATA binding site partially decreased CGRE enhancer activity. GATA-3 did not bind to CGRE when c-myb expression was silenced. c-Myb, GATA-3, Menin, and mixed lineage leukemia (MLL) bound to CGRE in human primary CD4(+) effector/memory cells. Moreover, c-myb silencing significantly decreased both methylation of histone H3K4 and acetylation of histone H3K9 at the IL-13 locus in CD4(+) effector/memory cells. Therefore, in addition to the strong enhancer effect for the transcription of IL-13, the c-Myb/GATA-3 complex recruits MLL to the CGRE for histone modification of the IL-13 locus during the differentiation of memory Th2 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039304      PMCID: PMC3221810          DOI: 10.4049/jimmunol.1100550

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development.

Authors:  Yuji Nakata; Anne C Brignier; Shenghao Jin; Yuan Shen; Stephen I Rudnick; Mayumi Sugita; Alan M Gewirtz
Journal:  Blood       Date:  2010-05-18       Impact factor: 22.113

Review 2.  CD4 T cells: fates, functions, and faults.

Authors:  Jinfang Zhu; William E Paul
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

Review 3.  MYB function in normal and cancer cells.

Authors:  Robert G Ramsay; Thomas J Gonda
Journal:  Nat Rev Cancer       Date:  2008-07       Impact factor: 60.716

Review 4.  Critical roles for c-Myb in hematopoietic progenitor cells.

Authors:  Kylie T Greig; Sebastian Carotta; Stephen L Nutt
Journal:  Semin Immunol       Date:  2008-06-26       Impact factor: 11.130

5.  c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.

Authors:  Yuji Nakata; Susan Shetzline; Chizuko Sakashita; Anna Kalota; Ravikumar Rallapalli; Stephen I Rudnick; Yi Zhang; Stephen G Emerson; Alan M Gewirtz
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

6.  c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

Authors:  Shenghao Jin; Huiwu Zhao; Yan Yi; Yuji Nakata; Anna Kalota; Alan M Gewirtz
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

7.  Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-kappaB and NFAT.

Authors:  Katrin Silbermann; Grit Schneider; Ralph Grassmann
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

Review 8.  GATA3 in development and cancer differentiation: cells GATA have it!

Authors:  Jonathan Chou; Sylvain Provot; Zena Werb
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

Review 9.  GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.

Authors:  I-Cheng Ho; Tzong-Shyuan Tai; Sung-Yun Pai
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

10.  A 3' enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells.

Authors:  Deborah C Solymar; Suneet Agarwal; Craig H Bassing; Frederick W Alt; Anjana Rao
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

View more
  13 in total

Review 1.  Histone methyltransferase and histone methylation in inflammatory T-cell responses.

Authors:  Shan He; Qing Tong; Dennis Keith Bishop; Yi Zhang
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

Review 2.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

Review 3.  Transcriptional regulation of T helper type 2 differentiation.

Authors:  Gap Ryol Lee
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

4.  Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor.

Authors:  Yu-Ting Tan; Lin Ye; Fei Xie; Ashley I Beyer; Marcus O Muench; Jiaming Wang; Zhu Chen; Han Liu; Sai-Juan Chen; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-31       Impact factor: 11.205

5.  PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer.

Authors:  Chao Wang; Yaping Feng; Chengyue Zhang; David Cheng; Renyi Wu; Yuqing Yang; Davit Sargsyan; Dibyendu Kumar; Ah-Ng Kong
Journal:  FASEB J       Date:  2019-11-29       Impact factor: 5.191

6.  IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells.

Authors:  Jonathan P Huber; Sarah R Gonzales-van Horn; Kole T Roybal; Michelle A Gill; J David Farrar
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

7.  Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

Authors:  Daniel H Fowler; Miriam E Mossoba; Seth M Steinberg; David C Halverson; David Stroncek; Hahn M Khuu; Frances T Hakim; Luciano Castiello; Marianna Sabatino; Susan F Leitman; Jacopo Mariotti; Juan C Gea-Banacloche; Claude Sportes; Nancy M Hardy; Dennis D Hickstein; Steven Z Pavletic; Scott Rowley; Andre Goy; Michele Donato; Robert Korngold; Andrew Pecora; Bruce L Levine; Carl H June; Ronald E Gress; Michael R Bishop
Journal:  Blood       Date:  2013-02-20       Impact factor: 22.113

8.  IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity.

Authors:  Yoichiro Ohne; Jonathan S Silver; LuAnn Thompson-Snipes; Magalie A Collet; Jean Philippe Blanck; Brandi L Cantarel; Alan M Copenhaver; Alison A Humbles; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

9.  The Clusters of Transcription Factors NFATC2, STAT5, GATA2, AP1, RUNX1 and EGR2 Binding Sites at the Induced Il13 Enhancers Mediate Il13 Gene Transcription in Response to Antigenic Stimulation.

Authors:  Mohammad Kamran; Jinyi Liang; Bing Liu; Yapeng Li; Junfeng Gao; Ashley Keating; Fathia Mohamed; Shaodong Dai; Richard Reinhardt; Yang Jiong; Zhongdao Wu; Hua Huang
Journal:  J Immunol       Date:  2020-11-13       Impact factor: 5.426

10.  PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.

Authors:  Takuya Yashiro; Masato Kubo; Hideoki Ogawa; Ko Okumura; Chiharu Nishiyama
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.